Overview

Efficacy of Pergoveris in Aged IVF Patients

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy between LH supplementation (Pergoveris) and non-LH supplementation (Follitropin alpha) in patients aged ≥ 35 years undergoing IVF treatment. Study hypothesis: Pergoveris (LH supplementation) is better than follitropin alpha (non-LH supplementation) for ovarian stimulation in aged IVF patients.

Phase:

N/A

Details

Lead Sponsor:

Vietnam National University

Treatments:

Follicle Stimulating Hormone